Brent Satterfield serves as Executive at Co-Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Brent Satterfield has executed 6 insider transactions totaling $11.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 11, 2018 involved purchasing 1,305 shares valued at $2.4K.
Brent Satterfield currently holds 2,275,000 shares of Co-Diagnostics, Inc. (CODX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brent Satterfield has been a net buyer of CODX stock. They have purchased $11.8M and sold $0 worth of shares.
Brent Satterfield's most recent insider trade was on May 11, 2018, when they purchased 1,305 shares at $1.82 per share.
Get notified when new Form 4 filings are submitted
| $1.91 |
| Discretionary |
| Apr 23, 2018 | CODX | $1.0K | Purchase | 500 | $2.02 | Discretionary |
| Apr 16, 2018 | CODX | $970 | Purchase | 500 | $1.94 | Discretionary |
| Apr 9, 2018 | CODX | $11.8M | Purchase | 2,400 | $4920.00 | Discretionary |
| Apr 9, 2018 | CODX | $4.9K | Purchase | 2,400 | $2.05 | Discretionary |